McKesson Ventures has donated $10,000 to the Alzheimer’s Association on behalf of ClearCare, a former portfolio company. Moving forward, McKesson Ventures intends to donate a portion of its financial returns from any positive exit to a charitable organization of that portfolio’s choosing, a move that demonstrates the firm’s ongoing commitment to the missions of its portfolios.

Tom Rodgers, Senior Vice President and Managing Director at McKesson Ventures commented, “Our Ventures program is ultimately focused on helping develop and scale innovations that will improve the lives of patients and their caregivers and the efficiency and quality of our own healthcare system.” He continued, “This approach further demonstrates our commitment to the ecosystem of entrepreneurs and partner organizations that share our conviction. We are pleased to have the opportunity to double down on ClearCare’s mission.”

Geoff Nudd, Founder and Chief Executive Officer of ClearCare reported that they were “thrilled” by the donation to the Alzheimer’s Association on their behalf. “We are grateful to McKesson Ventures for all of their support, both for our business during the early stages and our mission.”

McKesson Ventures first launched in 2014. To date, it has grown a portfolio of over 18 companies aiming to bring positive change to the global healthcare landscape. The McKesson Ventures team works with payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and others across the spectrum of care to build healthier organizations that help deliver better care to patients in every setting.

The idea for ClearCare started in 2006, when founder Geoff Nudd’s father struggled to coordinate care remotely for his elderly mother. What started as a way to help loved ones has become a company with over 100 US-Based employees and a 99% customer retention rate.